Literature DB >> 9021523

Serum protein standardization project in Japan: evaluation of an IFCC reference material (RPPHS/CRM470) and establishment of reference intervals.

Y Itoh1, K Ichihara, T Kanno, T Sugawara, A Ohkubo, Y Hirabayashi, S Igarashi, K Kawano, S Iwata, K Saito, T Kawai.   

Abstract

Reference preparation for proteins in human serum (RPPHS), also called Certified Reference Material 470 (CRM 470), was prepared by the international Federation of Clinical Chemistry (IFCC) and is intended to serve as a new international plasma protein reference material. It is now being introduced into Japan. RPPHS possesses many excellent properties, including safety, stability, and accuracy in value assignment. Moreover, the physicochemical properties of its proteins are identical to those of fresh serum, giving it immunochemical behavior that is commutable with that of existing reference materials and calibrators in given immunoassays. Reference intervals of 13 serum proteins were determined for the first time using nephelometry and a new working calibrator assigned from RPPHS, which seems certain to play a critical role in the global standardization of specific protein immunoassays.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9021523      PMCID: PMC6703103          DOI: 10.1002/(sici)1098-2825(1997)11:1<39::aid-jcla7>3.0.co;2-f

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  8 in total

1.  Measurement signal versus value in immunoassays for human plasmaproteins.

Authors:  S Baudner
Journal:  Scand J Clin Lab Invest Suppl       Date:  1991

2.  ELISA for anti-HCV antibody employing a shorter synthetic core region peptide.

Authors:  I Nakagiri; K Ichihara
Journal:  J Virol Methods       Date:  1995-03       Impact factor: 2.014

3.  Determination of reference intervals for 13 plasma proteins based on IFCC international reference preparation (CRM470) and NCCLS proposed guideline (C28-P,1992): trial to select reference individuals by results of screening tests and application of maximal likelihood method.

Authors:  K Ichihara; T Kawai
Journal:  J Clin Lab Anal       Date:  1996       Impact factor: 2.352

4.  Determination of reference intervals for 13 plasma proteins based on IFCC international reference preparation (CRM470) and NCCLS proposed guideline (C28-P, 1992): a strategy for partitioning reference individuals with validation based on multivariate analysis.

Authors:  K Ichihara; T Kawai
Journal:  J Clin Lab Anal       Date:  1997       Impact factor: 2.352

Review 5.  Modern aspects and requirements for the standardization of immunoassays for human plasma proteins.

Authors:  S Baudner
Journal:  J Clin Lab Anal       Date:  1993       Impact factor: 2.352

Review 6.  Why a new international reference preparation (IRP) for human plasma proteins?

Authors:  S Baudner
Journal:  J Clin Lab Anal       Date:  1993       Impact factor: 2.352

7.  A new international reference preparation for proteins in human serum.

Authors:  A M Johnson
Journal:  Arch Pathol Lab Med       Date:  1993-01       Impact factor: 5.534

8.  New international reference preparation for proteins in human serum (RPPHS).

Authors:  J T Whicher; R F Ritchie; A M Johnson; S Baudner; J Bienvenu; S Blirup-Jensen; A Carlstrom; F Dati; A M Ward; P J Svendsen
Journal:  Clin Chem       Date:  1994-06       Impact factor: 8.327

  8 in total
  8 in total

1.  Reference distributions for the positive acute phase proteins, alpha1-acid glycoprotein (orosomucoid), alpha1-antitrypsin, and haptoglobin: a comparison of a large cohort to the world's literature.

Authors:  R F Ritchie; G E Palomaki; L M Neveux; O Navolotskaia
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

2.  Reference distributions for the negative acute-phase proteins, albumin, transferrin, and transthyretin: a comparison of a large cohort to the world's literature.

Authors:  R F Ritchie; G E Palomaki; L M Neveux; O Navolotskaia
Journal:  J Clin Lab Anal       Date:  1999       Impact factor: 2.352

3.  Reference distributions for complement proteins C3 and C4: a comparison of a large cohort to the world's literature.

Authors:  Robert F Ritchie; Glenn E Palomaki; Louis M Neveux; Olga Navolotskaia
Journal:  J Clin Lab Anal       Date:  2004       Impact factor: 2.352

4.  Reference distributions for immunoglobulins A, G, and M: a comparison of a large cohort to the world's literature.

Authors:  R F Ritchie; G E Palomaki; L M Neveux; O Navolotskaia
Journal:  J Clin Lab Anal       Date:  1998       Impact factor: 2.352

5.  Measurement of serum IgA and C3 may predict the diagnosis of patients with IgA nephropathy prior to renal biopsy.

Authors:  Y Tomino; S Suzuki; H Imai; T Saito; T Kawamura; N Yorioka; T Harada; Y Yasumoto; H Kida; Y Kobayashi; M Endoh; H Sato; K Saito
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

6.  Significance of serum IgA levels and serum IgA/C3 ratio in diagnostic analysis of patients with IgA nephropathy.

Authors:  Atsuko Maeda; Tomohito Gohda; Kazuhiko Funabiki; Satoshi Horikoshi; Isao Shirato; Yasuhiko Tomino
Journal:  J Clin Lab Anal       Date:  2003       Impact factor: 2.352

7.  A comparison study between wide-range and high-sensitivity C-reactive protein assays (Roche Cobas c702) for low C-reactive protein concentration in patients with cardiovascular risk.

Authors:  Runqing Li; Yajun Xue; Tengjiao Wang; Lijun Gong; Peng Peng; Pan Xiong; Mingzhu Dai; Tongju Shao; Yuhan Hu; Xinchen Ye
Journal:  J Clin Lab Anal       Date:  2019-06-20       Impact factor: 2.352

8.  Comparison of C-reactive protein levels between serum and plasma samples on long-term frozen storage after a 13.8 year interval: the JMS Cohort Study.

Authors:  Shizukiyo Ishikawa; Kazunori Kayaba; Tadao Gotoh; Yosikazu Nakamura; Kazuomi Kario; Yoshihisa Ito; Eiji Kajii
Journal:  J Epidemiol       Date:  2007-07       Impact factor: 3.211

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.